Alpinumisoflavone ameliorates choroidal neovascularisation and fibrosis in age-related macular degeneration in in vitro and in vivo models
Abstract Age-related macular degeneration (AMD) is a major cause of vision loss in the elderly population. Anti-vascular endothelial growth factor (VEGF) antibody therapy is applicable to neovascularisation of AMD; however, the prevention of fibrosis after anti-VEGF monotherapy is an unmet medical n...
Main Authors: | Eunhye Yu, Yunjeong Song, Sun Mi Gu, Yang Hee Jo, Sang Won Yeon, Kyu Jin Han, Mi Kyeong Lee, Jung Kee Min, Jaesuk Yun |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-18531-y |
Similar Items
-
Matrix Metalloproteinase 10 Contributes to Choroidal Neovascularisation
by: Jorge González-Zamora, et al.
Published: (2022-06-01) -
Biomarkers of macular neovascularisation activity using optical coherence tomography angiography in treated stable neovascular age related macular degeneration
by: Daren Hanumunthadu, et al.
Published: (2023-02-01) -
Anti-VEGF therapy for choroidal neovascularisation previously treated with photodynamic therapy.
by: Jyothi, S, et al.
Published: (2010) -
Recurrence risk of myopic choroidal neovascularisation: a systematic review of current study
by: Andi Arus Victor, et al.
Published: (2023-12-01) -
Using choroidal thickness to detect myopic macular degeneration
by: Ran Liu, et al.
Published: (2024-02-01)